S 525 · 111th Congress · Health

Pharmaceutical Market Access and Drug Safety Act of 2009

Introduced 2009-03-04· Sponsored by Sen. Dorgan, Byron L. [D-ND]· Senate

Bill Progress

Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Sponsor introductory remarks on measure. (CR S2780-2781)(2009-03-05)

Plain Language Summary

[AI summary unavailable — showing source text] Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action …

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

15 Democrats4 Republicans1 Independent